23-6296135 · Philadelphia, PA
To prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention and compassionate care.
Total revenue
$98.8M
FY2023
Total expenses
$90.5M
FY2023
Net assets
$108.4M
FY2023
Operating margin
8.4%
NPLens analysis
FY18–FY2023 · from annual filings
Financial health
B
Derived analysis — not an official IRS designation.
Computed from FY2023 · derived analysis
FY2023 · program vs. administration vs. fundraising (Form 990, Part IX)
FY2023 · where revenue comes from (as reported)
Highest-paid officers, directors & key employees · FY2023.
Michael Young
Director
$1,747,691
Dr Robert Uzzo
President & CEO
$1,405,539
Amy Goldberg
Director
$1,128,445
John Ryan
Assistant Secretary
$770,935
Jonathan Chernoff
Chief Science Officer
$692,560
Each figure on this page traces to one of these source returns.
Health scores, efficiency ratios, peer percentiles, and outlier flags are derived analysis by NPLens — not official IRS designations. Figures are as reported on the organization's Form 990 filings. How these are computed →